The anti-inflammatory actions of PPARγ ligands [36–38], which are of relevance to thetreatment of atherosclerosis and cardiovascular disease, may also proveimportant for the treatment and prevention of cancer given the association ofchronic inflammation with increased cancer risk [39]. This evidence concerns the gene PPARG and cancer.